## PFG: Principal Financial Group, Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 -1.6% below STRENGTH zone (3.0-6.0%); PEG 1.50 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-5.0% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($86.04)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Piper Sandler Adjusts Price Target on Principal Financial Group to $100 From $94**
- Source: marketscreener.com | 20251223T114018 | Bullish | Relevance: 100%
- Piper Sandler has increased its price target for Principal Financial Group (NYSE: PFG) to $100, up from the previous $94. This adjustment reflects a positive outlook for the financial services company. Other firms have also recently updated their price targets for Principal Financial Group.

**2. MetLife (NYSE:MET) - Stock Analysis**
- Source: Simply Wall Street | 20251221T180809 | Neutral | Relevance: 64%
- This Simply Wall St analysis of MetLife (NYSE:MET) indicates the stock is trading 45.5% below its estimated fair value, with earnings forecast to grow by 16.08% annually and a reliable dividend of 2.79%. Key takeaways highlight digital expansion and international market growth driving revenue, supported by a focus on asset-light, fee-based businesses. The report also details financial performance, recent news, shareholder returns, and MetLife's company overview.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-23 | Piper Sandler | $100 | $94 | +6% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-23 | Piper Sandler | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 24 ($0.47M) |
| Sells | 3 ($0.42M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 37.5% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 6 |

**Top Holders:**
- Vanguard Group Inc: 9.8% (-0.8%)
- Blackrock Inc.: 7.2% (-0.9%)
- Nippon Life Insuranc: 6.5% (0.0%)
- State Street Corpora: 3.8% (-1.2%)
- Bank of America Corp: 3.0% (-31.9%)

### Key Risks

1. Momentum deterioration: MRS_10 falling (-5.0% 5d) with bearish MACD, trend may be turning.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.50 elevated, pricing in significant growth expectations. Forward P/E 9.6x attractive for 13% earnings growth. Analyst sentiment positive (1 raises, avg +6%). Institutional flow bearish (6 selling vs 3 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $19.9B |
| Beta | 0.89 |
| 52W Range | $68.39 - $92.10 |
| Short Interest | 2.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.50 |
| Forward P/E | 9.6 |
| Current P/E | 10.8 |
| YoY Growth | 12.7% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 3.3% to -1.6% (-5.0% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.6pp (needs >3.0% for momentum thesis). Underperforming sector by 3.5pp, stock-specific weakness. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: -SBL (Volatile).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -1.63% (CS: 38) | Neutral |
| RSI_14 | 62.1 | Neutral |
| MACD Histogram | -0.08 | Bearish |
| vs SMA20 | 1.020x | Above |
| vs SMA50 | 1.062x | Above |
| vs SMA200 | 1.113x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $89.52
- **Stop Loss:** $86.04 (3.9% risk)
- **Target:** $93.00 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 258
- **Position Value:** $23,096.16
- **Portfolio %:** 23.10%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

**Next:** 2026-02-05 (Est: $2.22)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.20 | $2.10 | -4.5% |
| 2025Q2 | $1.97 | $2.16 | +9.6% |
| 2025Q1 | $1.83 | $1.81 | -1.0% |
| 2024Q4 | $1.93 | $1.94 | +0.4% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*